ArticleHealthcare (Basel, Switzerland)2025
Knowledge Gaps Among Brazilian Healthcare Professionals Regarding Oropouche Virus: A National Cross-Sectional Study.
Article in Healthcare (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
BACKGROUND/
objectiveOropouche virus (OROV-
methodsA cross-sectional, questionnaire-based study was conducted between February 2024 and March 2025 with 760 healthcare professionals across 21 Brazilian states. Participants represented various professional categories, including nursing, medicine, pharmacy, and biomedical sciences. The survey assessed knowledge on OROV epidemiology, clinical recognition, diagnostic practices, and compulsory notification.
resultsAmong participants, 37.4% had never heard of OROV, and 38.0% had heard of it but knew little about it. Most professionals first learned about the virus within the past year (31.8%). The majority (86.1%) reported not having received information about OROV during undergraduate education. Only 21.9% knew which diagnostic test to request, and 64.7% were aware that OROV is subject to mandatory notification. Notably, 71.2% were unaware of the virus's potential neurological complications.
conclusionsThese findings reveal a significant gap in the education and training of healthcare professionals regarding OROV, even in endemic areas. The results underscore the need for curricular reform, expanded continuing education, and stronger integration of OROV into national epidemiological surveillance efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.